Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 11/2019

01-11-2019 | Original Article

The implementation of rapid microbial identification via MALDI-ToF reduces mortality in gram-negative but not gram-positive bacteremia

Authors: Hila Zadka, Eli Raykhshtat, Boris Uralev, Nancy Bishouty, Ahuva Weiss-Meilik, Amos Adler

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 11/2019

Login to get access

Abstract

Our goals were to study the effect of rapid microbial identification (RMI) of positive blood culture on patient’s outcome and to identify specific microbiological characteristics related to clinical benefit of RMI. This was a retrospective-cohort study of hospitalized, adult patients with bacteremia. The outcome of patients with bacteremia episodes was compared before vs. after the initiation of RMI. RMI was done by matrix-assisted laser desorption/ionization time-of-flight testing of microcolonies. The study included 1460 and 2710 cases in the pre- and post-intervention periods, respectively. There were similar rates of gram-negative, gram-positive, anaerobes, and polymicrobial infections, but higher rate of contaminants in the intervention period (39.9 vs. 43.7%, p = 0.019). The median time-to-identification decreased from 47.5 to 21.3 h (p < 0.001). Post-intervention, the median LOS declined from 10.83 to 9.79 days (p = 0.016), the rate of ICU transfer declined from 13.8 to 11.6% (p = 0.054), and the mortality rate declined from 20.9 to 18.3% (p = 0.047). The improvement in outcome variables remained statistically significant in multivariate analysis when performed for all episodes and non-contaminants but not for contaminants. The mortality declined in gram-negative bacteremia (20% vs. 15.5%, p = 0.005 in multivariate analysis) but not in gram-positive bacteremia (18.1% vs. 18.5%). RMI reduces mortality from gram-negative but not gram-positive bacteremia.
Appendix
Available only for authorised users
Literature
1.
go back to reference Buehler SS, Madison B, Snyder SR, Derzon JH, Cornish NE, Saubolle MA et al (2016) Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a laboratory medicine best practices systematic review and meta-analysis. Clin Microbiol Rev 29:59–103CrossRef Buehler SS, Madison B, Snyder SR, Derzon JH, Cornish NE, Saubolle MA et al (2016) Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a laboratory medicine best practices systematic review and meta-analysis. Clin Microbiol Rev 29:59–103CrossRef
2.
go back to reference Knols BG, Smallegange RC, Tacconelli E, Magrini N, Kahlmeter G, Singh N (2016) Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Lancet Infect Dis 9:535–536CrossRef Knols BG, Smallegange RC, Tacconelli E, Magrini N, Kahlmeter G, Singh N (2016) Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Lancet Infect Dis 9:535–536CrossRef
3.
go back to reference Banerjee R, Teng CB, Cunningham SA, Ihde SM, Steckelberg JM, Moriarty JP et al (2015) Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing. Clin Infect Dis 61:1071–1080CrossRef Banerjee R, Teng CB, Cunningham SA, Ihde SM, Steckelberg JM, Moriarty JP et al (2015) Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing. Clin Infect Dis 61:1071–1080CrossRef
4.
go back to reference Ly T, Gulia J, Pyrgos V, Waga M, Shoham S (2008) Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time. Ther Clin Risk Manag 4:637–640CrossRef Ly T, Gulia J, Pyrgos V, Waga M, Shoham S (2008) Impact upon clinical outcomes of translation of PNA FISH-generated laboratory data from the clinical microbiology bench to bedside in real time. Ther Clin Risk Manag 4:637–640CrossRef
5.
go back to reference Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Land GA et al (2013) Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med 237:1247–1254CrossRef Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Land GA et al (2013) Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med 237:1247–1254CrossRef
6.
go back to reference Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Land GA et al (2013) Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med 137:1247–1254CrossRef Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Land GA et al (2013) Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med 137:1247–1254CrossRef
7.
go back to reference Beganovic M, Costello M, Wieczorkiewicz SM (2017) MALDI-TOF alone versus MALDI-TOF combined with real-time antimicrobial stewardship interventions on time to optimal antimicrobial therapy in patients with positive blood cultures. J Clin Microbiol 55:1437–1445CrossRef Beganovic M, Costello M, Wieczorkiewicz SM (2017) MALDI-TOF alone versus MALDI-TOF combined with real-time antimicrobial stewardship interventions on time to optimal antimicrobial therapy in patients with positive blood cultures. J Clin Microbiol 55:1437–1445CrossRef
8.
go back to reference Faron ML, Buchan BW, Ledeboer NA (2017) Matrix-assisted laser desorption ionization–time of flight mass spectrometry for use with positive blood cultures: methodology, performance, and optimization. J Clin Microbiol 55:3328–3338CrossRef Faron ML, Buchan BW, Ledeboer NA (2017) Matrix-assisted laser desorption ionization–time of flight mass spectrometry for use with positive blood cultures: methodology, performance, and optimization. J Clin Microbiol 55:3328–3338CrossRef
9.
go back to reference The Clinical and Laboratory Standards Institute (2016) M100S performance standards for antimicrobial susceptibility testing, 26th edn. Clin Lab Stand Institute, Wayne, PA The Clinical and Laboratory Standards Institute (2016) M100S performance standards for antimicrobial susceptibility testing, 26th edn. Clin Lab Stand Institute, Wayne, PA
10.
go back to reference Idelevich EA, Schüle I, Grünastel B, Wüllenweber J, Peters G, Becker K (2014) Rapid identification of microorganisms from positive blood cultures by MALDI-TOF mass spectrometry subsequent to very short-term incubation on solid medium. Clin Microbiol Infect 20:1001–1006CrossRef Idelevich EA, Schüle I, Grünastel B, Wüllenweber J, Peters G, Becker K (2014) Rapid identification of microorganisms from positive blood cultures by MALDI-TOF mass spectrometry subsequent to very short-term incubation on solid medium. Clin Microbiol Infect 20:1001–1006CrossRef
11.
go back to reference Gonzalez MD, Weber CJ, Burnham CAD (2016) Rapid identification of microorganisms from positive blood cultures by testing early growth on solid media using matrix-assisted laser desorption ionization-time of flight mass spectrometry. Diagn Microbiol Infect Dis 85:133–135CrossRef Gonzalez MD, Weber CJ, Burnham CAD (2016) Rapid identification of microorganisms from positive blood cultures by testing early growth on solid media using matrix-assisted laser desorption ionization-time of flight mass spectrometry. Diagn Microbiol Infect Dis 85:133–135CrossRef
12.
go back to reference Verroken A, Defourny L, Lechgar L, Magnette A, Delmée M, Glupczynski Y (2014) Reducing time to identification of positive blood cultures with MALDI-TOF MS analysis after a 5-h subculture. Eur J Clin Microbiol Infect Dis 34:405–413CrossRef Verroken A, Defourny L, Lechgar L, Magnette A, Delmée M, Glupczynski Y (2014) Reducing time to identification of positive blood cultures with MALDI-TOF MS analysis after a 5-h subculture. Eur J Clin Microbiol Infect Dis 34:405–413CrossRef
13.
go back to reference Kohlmann R, Hoffmann A, Geis G, Gatermann S (2015) MALDI-TOF mass spectrometry following short incubation on a solid medium is a valuable tool for rapid pathogen identification from positive blood cultures. Int J Med Microbiol 305:469–479CrossRef Kohlmann R, Hoffmann A, Geis G, Gatermann S (2015) MALDI-TOF mass spectrometry following short incubation on a solid medium is a valuable tool for rapid pathogen identification from positive blood cultures. Int J Med Microbiol 305:469–479CrossRef
14.
go back to reference Verroken A, Defourny L, Le Polain De Waroux O, Belkhir L, Laterre PF, Delmée M et al (2016) Clinical impact of MALDI-TOF MS identification and rapid susceptibility testing on adequate antimicrobial treatment in sepsis with positive blood cultures. PLoS One 11:1–15 Verroken A, Defourny L, Le Polain De Waroux O, Belkhir L, Laterre PF, Delmée M et al (2016) Clinical impact of MALDI-TOF MS identification and rapid susceptibility testing on adequate antimicrobial treatment in sepsis with positive blood cultures. PLoS One 11:1–15
15.
go back to reference MacVane SH, Nolte FS (2016) Benefits of adding a rapid PCR-based blood culture identification panel to an established antimicrobial stewardship program. J Clin Microbiol 54:2455–2463CrossRef MacVane SH, Nolte FS (2016) Benefits of adding a rapid PCR-based blood culture identification panel to an established antimicrobial stewardship program. J Clin Microbiol 54:2455–2463CrossRef
16.
go back to reference Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL, Isip J et al (2013) Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis 57:1237–1245CrossRef Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL, Isip J et al (2013) Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis 57:1237–1245CrossRef
17.
go back to reference Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Peterson LE et al (2014) Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. J Inf Secur 69:216–225 Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Peterson LE et al (2014) Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. J Inf Secur 69:216–225
18.
go back to reference Wenzler E, Goff DA, Mangino JE, Reed EE, Wehr A, Bauer KA (2016) Impact of rapid identification of Acinetobacter Baumannii via matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with antimicrobial stewardship in patients with pneumonia and/or bacteremia. Diagn Microbiol Infect Dis 84:63–68CrossRef Wenzler E, Goff DA, Mangino JE, Reed EE, Wehr A, Bauer KA (2016) Impact of rapid identification of Acinetobacter Baumannii via matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with antimicrobial stewardship in patients with pneumonia and/or bacteremia. Diagn Microbiol Infect Dis 84:63–68CrossRef
19.
go back to reference Nagel JL, Huang AM, Kunapuli A, Gandhi TN, Washer LL, Lassiter J et al (2014) Impact of antimicrobial stewardship intervention on coagulase-negative Staphylococcus blood cultures in conjunction with rapid diagnostic testing. J Clin Microbiol 52:2849–2854CrossRef Nagel JL, Huang AM, Kunapuli A, Gandhi TN, Washer LL, Lassiter J et al (2014) Impact of antimicrobial stewardship intervention on coagulase-negative Staphylococcus blood cultures in conjunction with rapid diagnostic testing. J Clin Microbiol 52:2849–2854CrossRef
20.
go back to reference Wong JR, Bauer KA, Mangino JE, Goff DA (2012) Antimicrobial stewardship pharmacist interventions for coagulase-negative staphylococci positive blood cultures using rapid polymerase chain reaction. Ann Pharmacother 46:1484–1490CrossRef Wong JR, Bauer KA, Mangino JE, Goff DA (2012) Antimicrobial stewardship pharmacist interventions for coagulase-negative staphylococci positive blood cultures using rapid polymerase chain reaction. Ann Pharmacother 46:1484–1490CrossRef
21.
go back to reference Clerc O, Prod’hom G, Senn L, Jaton K, Zanetti G, Calandra T et al (2014) Matrix-assisted laser desorption ionization time-of-flight mass spectrometry and PCR-based rapid diagnosis of Staphylococcus aureus bacteraemia. Clin Microbiol Infect 20:355–360CrossRef Clerc O, Prod’hom G, Senn L, Jaton K, Zanetti G, Calandra T et al (2014) Matrix-assisted laser desorption ionization time-of-flight mass spectrometry and PCR-based rapid diagnosis of Staphylococcus aureus bacteraemia. Clin Microbiol Infect 20:355–360CrossRef
22.
go back to reference Hall KK, Lyman JA (2016) Updated review of blood culture contamination. Clin Microbiol Rev 19:788–802CrossRef Hall KK, Lyman JA (2016) Updated review of blood culture contamination. Clin Microbiol Rev 19:788–802CrossRef
Metadata
Title
The implementation of rapid microbial identification via MALDI-ToF reduces mortality in gram-negative but not gram-positive bacteremia
Authors
Hila Zadka
Eli Raykhshtat
Boris Uralev
Nancy Bishouty
Ahuva Weiss-Meilik
Amos Adler
Publication date
01-11-2019
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 11/2019
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-019-03640-w

Other articles of this Issue 11/2019

European Journal of Clinical Microbiology & Infectious Diseases 11/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.